Titles
- Telemedicine in California: progress, challenges, and opportunities1
- Telemedicine in Mississippi: defining boundaries for a new frontier1
- Telemedicine in sexual and reproductive health1
- Telemedicine: what should the post-pandemic regulatory and payment landscape look like?1
- Telepharmacy rules and statutes: a 3-year update for all 50 states1
- Temporary policy for compounding of certain drugs for hospitalized patients by outsourcing facilities during the COVID-19 public health emergency (revised)1
- Temporary policy for compounding of certain drugs for hospitalized patients by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency (revised)1
- Temporary policy for manufacture of alcohol for incorporation into alcohol-based hand sanitizer products during the public health emergency (COVID-19)1
- Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)2
- Temporary policy on Prescription Drug Marketing Act requirements for distribution of drug samples during the COVID-19 public health emergency1
- Temporary policy on repackaging or combining propofol drug products during the COVID-19 public health emergency1
- Temporary policy regarding accredited third-party certification program onsite observation and certificate duration requirements during the COVID-19 public health emergency1
- Temporary policy regarding non-standard PPE practices for sterile compounding by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency1
- Temporary policy regarding preventive controls and FSVP food supplier verification onsite audit requirements during the COVID-19 public health emergency: guidance for industry1
- Ten ways that the House American Health Care Act could affect women1
- Ten years of the Affordable Care Act: major gains and ongoing disparities1
- Tennessee Medicaid Fraud Control Unit: 2017 onsite inspection1
- Termination and closure of poor quality nursing homes: what are the options?1
- Testing and labeling medical devices for safety in the magnetic resonance (MR) environment: guidance for industry and Food and Drug Administration staff1
- Testing for biotin interference in in vitro diagnostic devices1